Document is current
Any future updates will be listed below
-
Authors
Arastoo, Mohammad
Penny, Lewis K.
Lofthouse, Richard
Abdallah, Aya
Abrahamsson, Anna
Marini, Pietro
Melis, Valeria
Riedel, Gernot
Harrington, Charles R.
Wischik, Claude M.
Porter, Andrew
Palliyil, Soumya
- License Information
-
More Information
Article History
Received: 29 May 2024
Accepted: 15 August 2024
First Online: 2 October 2024
Change Date: 13 November 2024
Change Type: Update
Change Details: The paper was amended to remove the track changes in Supplementary Material 1 file.
Declarations
:
: Not Applicable.
: Not Applicable.
: CRH and CMW are employees and officers of TauRx Therapeutics Ltd. LKP is employed by WisTa Laboratories Ltd. MA, LKP, RL, CRH, CMW, AP and SP are inventors on patent applications relating to tau-based antibodies that are owned by GTInvent Limited, that is an affiliate of GTD Diagnostics and TauRx Therapeutics Ltd. Research activity performed by the Scottish Biologics Facility, University of Aberdeen is funded by TauRx Therapeutics Ltd. and GT Diagnostics (UK) Ltd (PAR1577).
